ArticleEpidemiology and infection2026
What is the burden of respiratory syncytial virus outbreaks in care homes? An enhanced surveillance study in England, winter 2024/25.
Article in Epidemiology and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Care homes are vulnerable to respiratory syncytial virus (RSV) outbreaks, with residents at risk of severe disease outcomes, though surveillance studies are lacking. In September 2024, RSV vaccination was introduced for adults in England aged 75-79 years, excluding most residents (median age 86 years). Between October 2024 and March 2025, we prospectively extracted information on RSV outbreaks in English care homes reported to UK Health Security Agency (UKHSA). Enhanced surveillance questionnaires (ESQs) were completed for a sample of outbreaks, including information on symptomatic residents, testing, and outcomes. Acute respiratory infection (ARI) cases were defined symptomatically, RSV cases based on test-positive RSV (≤5 residents tested per home), and RSV outbreaks as ARI outbreaks including ≥1 RSV case. We described outbreak trends, attack rates, hospitalizations, and deaths. Of 2419 ARI outbreaks in care homes, 222 (9%) were RSV outbreaks, with additional respiratory viruses identified in 69 (31%). Among 48 (22%) RSV outbreaks completing ESQs, the median ARI attack rate was 15% (IQR 10%-24%). Of 350 ARI cases, 32% (112) were confirmed RSV cases on routine testing, 20% (71) were hospitalized, and 6% (20) died. These findings demonstrate the vulnerability of care home residents to RSV infection, hospitalization, and death, which are potentially preventable through vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.